Loading...
Jin Medical International Ltd.
ZJYL•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.65
$-0.01(-2.05%)
Jin Medical International Ltd. (ZJYL) Financial Performance & Income Statement Overview
Review Jin Medical International Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.57%
↑ 18.57%
Operating Income Growth
26.91%
↑ 26.91%
Net Income Growth
27.71%
↑ 27.71%
Operating Cash Flow Growth
-138.87%
↓ 138.87%
Operating Margin
15.48%
↑ 15.48%
Gross Margin
40.89%
↑ 40.89%
Net Profit Margin
15.64%
↑ 15.64%
ROE
13.35%
↑ 13.35%
ROIC
12.70%
↑ 12.70%
Jin Medical International Ltd. (ZJYL) Income Statement & Financial Overview
Review Jin Medical International Ltd.'s (ZJYL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.47M | $6.47M | $5.28M | $5.28M |
| Cost of Revenue | $3.57M | $3.57M | $3.38M | $3.38M |
| Gross Profit | $2.91M | $2.91M | $1.90M | $1.90M |
| Gross Profit Ratio | $0.45 | $0.45 | $0.36 | $0.36 |
| R&D Expenses | $443840.00 | $443840.00 | $304823.00 | $304823.00 |
| SG&A Expenses | $1.23M | $1.23M | $948724.00 | $948724.00 |
| Operating Expenses | $1.70M | $1.70M | $1.28M | $1.23M |
| Total Costs & Expenses | $5.27M | $5.27M | $4.66M | $4.61M |
| Interest Income | $0.00 | $0.00 | $681588.00 | $340794.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $58889.00 | $58889.00 | $60023.00 | $60023.00 |
| EBITDA | $1.26M | $1.26M | $674642.00 | $674642.00 |
| EBITDA Ratio | $0.20 | $0.20 | $0.13 | $0.13 |
| Operating Income | $1.20M | $1.20M | $614619.00 | $614619.00 |
| Operating Income Ratio | $0.19 | $0.19 | $0.12 | $0.12 |
| Other Income/Expenses (Net) | -$119600.00 | -$119600.00 | $392083.00 | $392083.00 |
| Income Before Tax | $1.09M | $1.09M | $1.007M | $1.007M |
| Income Before Tax Ratio | $0.17 | $0.17 | $0.19 | $0.19 |
| Income Tax Expense | $227433.00 | $227433.00 | $154507.00 | $154507.00 |
| Net Income | $940917.00 | $940917.00 | $897047.00 | $897047.00 |
| Net Income Ratio | $0.15 | $0.15 | $0.17 | $0.17 |
| EPS | $0.006 | $0.006 | $0.006 | $0.006 |
| Diluted EPS | $0.006 | $0.006 | $0.006 | $0.006 |
| Weighted Avg Shares Outstanding | $156.56M | $156.56M | $156.42M | $156.42M |
| Weighted Avg Shares Outstanding (Diluted) | $156.55M | $156.55M | $156.40M | $156.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan